Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Unknown 3Completed 3Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 2Genitourinary 1

Conditions

Febrile Neutropenia 2Urinary Bladder Neoplasms 1Sepsis 1Neoplasms 1Fever 1Emergencies 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Meropenem × Clear all
NCT05393505 2022-12-06

FRANCiS-NF

The University of Hong Kong

Phase 4 Unknown
344 enrolled
Classical hematology

Emergencies, Neoplasms, Sepsis, Febrile Neutropenia

NCT05392634 2022-05-31

MACS

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Unknown
98 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02463747 2015-06-04

RR

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
110 enrolled
Classical hematology

Fever, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡